The Carotid and Middle Cerebral Artery Occlusion Surgery Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 330 participants.

Also called NCT01758614

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 330 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01758614
Other papers using this trial's data
  • CT Perfusion for Predicting Ischemic Stroke in Patients With Symptomatic Carotid or Middle Cerebral Artery Occlusion: A Post Hoc Analysis of the CMOSS Study Stroke, 2025-09 DOI, PubMed 40534574
  • Determining the Optimal Age for Extracranial-Intracranial Bypass Surgery: A Post Hoc Analysis of the CMOSS Randomized Trial Stroke, 2025-02 DOI, PubMed 39727027
  • Extracranial-Intracranial Bypass and Risk of Stroke and Death in Patients With Symptomatic Artery Occlusion: The CMOSS Randomized Clinical Trial JAMA, 2023-08-22 DOI, PubMed 37606672, PMC10445185 Not in the PMC Open Access subset.
  • Qualifying Event and Recurrence of Ischemic Stroke in Symptomatic Artery Occlusion: A Post Hoc Analysis of CMOSS Journal of the American Heart Association, 2024-07-02 DOI, PubMed 38934799, PMC11255723 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01758614. Randomized; single masking; primary purpose treatment. Start 2013-06-06 (actual); primary completion 2018-03-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Carotid and Middle Cerebral Artery Occlusion Surgery Study
Acronym
CMOSS
Condition
Carotid Artery Occlusion
Condition
Middle Cerebral Artery Occlusion
Condition
Stroke
Intervention (Procedure)
bypass surgery
Intervention (Drug)
Aspirin
Intervention (Drug)
Clopidogrel
Lead sponsor
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct01758614
Content hash
91367bf8e2c28172840a0ac0d9f5947bca75c53bec7ac9015fa601b11932b535